Rare phylotypes in stone, stool, and urine microbiomes are associated with urinary stone disease/Experiment 2

From BugSigDB


Reviewed Marked as Reviewed by Peace Sandy on 2024-2-26

Curated date: 2023/10/12

Curator: Joju

Revision editor(s): Joju, Chloe

Subjects

Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Urine Urine,urine
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Urolithiasis calculus,kidney stone,urinary stones,urolithiasis,Urolithiasis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
urinary stone disease patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
patients with urinary stone disease
Group 0 sample size Number of subjects in the control (unexposed) group
136
Group 1 sample size Number of subjects in the case (exposed) group
201
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
TEST
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
DESeq2
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05


Signature 1

Reviewed Marked as Reviewed by Peace Sandy on 2024-2-26

Curated date: 2023/10/30

Curator: Joju

Revision editor(s): Joju

Source: Figure 7

Description: Bubble plot showing the fold change of differentially abundant rare (B) taxa associated with health disparities (control and USD phenotypes) in urine samples.

Abundance in Group 1: increased abundance in urinary stone disease patients

NCBI Quality ControlLinks
Acinetobacter
Actinomyces
Anaerococcus
Atopobium
Bacteroides
Blautia
Bradyrhizobium
Brevibacterium
Chryseobacterium
Clostridia
Comamonadaceae
Corynebacterium
Elizabethkingia
Facklamia
Fastidiosipila
Flavobacterium
Fusicatenibacter
Fusobacterium
Gallicola
Helcococcus
Kocuria
Lachnospiraceae
Lactobacillus
Lawsonella
Methylobacterium
Murdochiella
Olsenella
Peptococcus
Peptoniphilus
Porphyromonas
Prevotella
Pseudomonas
Ruminococcus
Sphingomonas
Streptococcus
Subdoligranulum
Veillonella
Tolumonas
Undibacterium
Fluviicola
Massilia
Chujaibacter
Rothia

Revision editor(s): Joju